Free Trial

Exponent Q2 2024 Earnings Report

Exponent logo
$76.74 -1.78 (-2.26%)
As of 10:39 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Exponent EPS Results

Actual EPS
$0.57
Consensus EPS
$0.50
Beat/Miss
Beat by +$0.07
One Year Ago EPS
$0.50

Exponent Revenue Results

Actual Revenue
$132.43 million
Expected Revenue
$130.83 million
Beat/Miss
Beat by +$1.60 million
YoY Revenue Growth
+2.10%

Exponent Announcement Details

Quarter
Q2 2024
Time
After Market Closes

Conference Call Resources

Conference Call Audio

Remove Ads

Exponent Earnings Headlines

Trump Allies Confirm Exec Order 14024 Triggers Dollar Collapse
Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.
See More Exponent Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Exponent? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Exponent and other key companies, straight to your email.

About Exponent

Exponent (NASDAQ:EXPO), together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.

View Exponent Profile

More Earnings Resources from MarketBeat